Preterm Labor and Preterm Birth

• Activation of the hypothalamic-pituitary-adrenal (HPA) axis with fetal contribution: The fetal adrenal gland produces dehydroepiandrosterone sulfate (DHEAS), which is converted to estrogen in the placenta. Increased fetal-placental estrogen production shifts the myometrial response from progesterone-mediated quiescence to oxytocin and prostaglandin responsiveness. This mechanism explains why preterm labor often precedes fetal maturity and why interventions targeting progesterone signaling have proven efficacy. The 17-hydroxyprogesterone caproate (17-OHP) mechanism of action directly opposes this pathway by maintaining myometrial quiescence.

• Intrauterine inflammation and infection pathway: Ascending infection from the lower genital tract or hematogenous spread of pathogens triggers toll-like receptor (TLR) signaling in fetal membranes, decidua, and myometrium. This activates NF-κB and mitogen-activated protein kinase (MAPK) cascades, inducing production of pro-inflammatory cytokines (IL-6, IL-8, TNF-α) and prostaglandins (PGE2, PGF2α). Prostaglandins directly stimulate myometrial contractility and promote cervical ripening through matrix metalloproteinase (MMP-9) upregulation. Microorganisms are detected in amniotic fluid in approximately 25-30% of women with spontaneous preterm labor, though culture-negative amniotic fluid with elevated inflammatory markers occurs frequently. This mechanism explains the association between bacterial vaginosis, sexually transmitted infections, and PTB.

• Placental insufficiency and maternal-fetal mismatch: Inadequate placental development, abnormal trophoblastic invasion, or maternal vascular disorders (preeclampsia, intrauterine growth restriction) trigger fetal stress responses. Chronic fetal hypoxemia activates the fetal HPA axis, increasing cortisol and adrenal androgen production, which accelerates the switch to labor-promoting endocrine signals. Additionally, uteroplacental ischemia increases oxidative stress, activating endothelial dysfunction pathways and promoting myometrial contractility.

• Cervical remodeling and structural weakness: Progressive cervical softening and dilation before term results from increased hyaluronic acid and water content, altered collagen cross-linking, and increased MMP activity (especially MMP-2 and MMP-9). In some cases, cervical insufficiency reflects intrinsic weakness from prior cervical trauma (dilation and curettage, loop electrosurgical excision procedure, conization) or genetic predisposition. This mechanical weakening is often insufficient alone to cause PTB but becomes significant when combined with inflammatory or hormonal stimuli.

• Myometrial contractility transformation: Progressive desensitization to progesterone occurs through multiple mechanisms: decreased progesterone receptor expression, altered progesterone receptor isoform ratios (PR-A:PR-B), and impaired progesterone-responsive element binding. Simultaneously, myometrial cells become increasingly responsive to oxytocin and prostaglandins through upregulation of oxytocin receptor (OXTR) and prostaglandin receptor genes (PTGER2, PTGFR). Gap junction protein (connexin-43) expression increases, facilitating coordinated uterine contractions that transition from Braxton-Hicks contractions to labor-effective contractions.

• Oxidative stress and antiinflammatory pathway dysfunction: Reduced antioxidant capacity (decreased superoxide dismutase, catalase activity) combined with increased reactive oxygen species production from leukocyte infiltration promotes tissue damage, increases prostaglandin production, and perpetuates myometrial inflammation. In some cases, inadequate IL-10 and TGF-β responses (anti-inflammatory cytokines) fail to counter pro-inflammatory signals, allowing inflammation to persist.

• Intrauterine infection (chorioamnionitis/funisitis): Bacterial vaginosis, Group B Streptococcus (GBS), Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium are frequently isolated from amniotic fluid in spontaneous PTL. The infectious burden correlates with inflammatory marker levels (elevated IL-6, amniotic fluid glucose <15 mg/dL, positive Gram stain). Women with bacterial vaginosis have approximately 1.5-fold increased risk; if present with symptoms, the risk approaches 2-3 fold. Ureaplasma urealyticum is controversial but frequently cultured from preterm amniotic fluid.

• Maternal medical conditions: Diabetes mellitus (particularly with poor glycemic control or preeclampsia), chronic hypertension, systemic lupus erythematosus with antiphospholipid syndrome, hyperthyroidism, and severe asthma increase PTB risk through placental insufficiency, maternal inflammation, or iatrogenic preterm delivery. Periodontal disease (with elevated maternal inflammatory markers) shows modest associations. Obesity paradoxically reduces PTB risk in some populations but is associated with maternal complications.

• Obstetric/uterine factors: Multiple gestations (twins have ~35% PTB rate, triplets >50%), history of prior spontaneous PTB (risk increases with number of prior early PTBs; one prior PTB at <32 weeks confers ~40% recurrence risk), cervical insufficiency, uterine anomalies (septate uterus, unicornuate uterus), and prior extensive uterine instrumentation. Polyhydramnios increases PTB risk through increased uterine distension and myometrial stretch.

• Maternal demographic and socioeconomic factors: Non-Hispanic Black women have 1.5-2 fold higher PTB rates independent of clinical risk factors, suggesting genetic or environmental factors not fully elucidated. Advanced maternal age (>35 years), maternal age <17 years, low socioeconomic status, limited prenatal care, and psychological stress all associate with increased PTB risk. Stress-related elevation of maternal cortisol may accelerate fetal HPA axis activation.

• Maternal behavioral/lifestyle factors: Smoking (increases risk ~1.5 fold through placental insufficiency and increased maternal stress hormones), cocaine and methamphetamine use, poor nutritional status (low folate, iron deficiency anemia), and inadequate gestational weight gain. Maternal anemia (Hgb <10 g/dL) may reduce oxygen delivery to the placenta.

• Fetal and placental factors: Intrauterine growth restriction (IUGR; risk depends on severity and gestational age), fetal anomalies (particularly those requiring early delivery or associated with polyhydramnios), and placental pathology (placental abruption, preeclampsia with fetal involvement, placental insufficiency). Fetal infection (such as cytomegalovirus, toxoplasmosis) rarely causes PTL.

• Iatrogenic/medically indicated preterm birth: Indications include maternal preeclampsia with severe features, HELLP syndrome, placental abruption, maternal hemorrhage, fetal distress, and severe IUGR. These represent approximately 30-40% of all PTBs and warrant early delivery despite prematurity risks.

• Idiopathic spontaneous preterm labor: Despite thorough investigation, 40-50% of women with spontaneous PTL have no identifiable cause, suggesting genetic predisposition, subclinical infection, or yet-undiscovered pathophysiologic mechanisms.

• Regular uterine contractions: Women describe rhythmic lower abdominal cramping or tightening, often occurring at regular intervals (contractions every 5-10 minutes in established labor). The contractions should persist for at least 1-2 hours to warrant evaluation. Early contractions may be mild and perceived as Braxton-Hicks contractions, delaying care-seeking. The patient should quantify frequency, duration, and intensity ("Does it feel different from what you experienced in prior pregnancies?").

• Vaginal bleeding or bloody discharge: Light vaginal bleeding can occur from cervical irritation during contractions or from cervical trauma during speculum examination. Heavy bleeding or bleeding with abdominal pain should prompt investigation for placental abruption or subchorionic hemorrhage. Pink or bloodstained mucus ("bloody show") results from cervical dilation and mucus plug expulsion.

• Vaginal fluid leakage or increased discharge: Clear or yellowish vaginal fluid suggests either increased cervical mucus (from cervical irritation or estrogen effect) or premature rupture of membranes (PROM). The patient may describe soaking through pads or continuous leakage versus intermittent spotting. PROM is present in approximately 25-35% of preterm births and requires separate management.

• Pelvic pressure or low back pain: Descent of the presenting part or increased intrauterine pressure produces sensations of pelvic heaviness or low back discomfort. Sharp perineal pain is unusual in PTL and should prompt evaluation for other causes (round ligament pain, sacroiliac joint dysfunction).

• Abdominal or flank pain: Constant severe pain suggests complications such as placental abruption, appendicitis, or pyelonephritis rather than uncomplicated PTL. Mild to moderate intermittent cramping confined to the lower abdomen is typical of PTL.

• Fever or systemic symptoms: Maternal fever (temperature >100.4°F/38°C) suggests underlying chorioamnionitis, pyelonephritis, appendicitis, or other infection. Associated symptoms (chills, malaise, myalgias) indicate systemic infection or sepsis. Maternal tachycardia and leukocytosis may reflect labor stress or underlying infection.

• Fetal heart rate abnormalities on initial monitoring: The fetal heart rate tracing may show tachycardia (FHR >160 bpm), variable decelerations, or diminished variability if fetal distress is present. In chorioamnionitis, fetal tachycardia is common. Repetitive late decelerations suggest placental insufficiency.

• Physical examination findings: Speculum examination reveals cervical dilation, effacement, and softening. The cervix may appear erythematous if inflamed (suggesting infection). Pooling of amniotic fluid in the posterior vaginal fornix suggests PROM. Cervical dilation ≥3 cm with regular contractions constitutes active preterm labor. Digital cervical examination determines dilation, effacement, station, and consistency. Fetal fibronectin (fFN) in vaginal fluid indicates placental injury (though positive results are nonspecific). Uterine tenderness on palpation suggests placental abruption or chorioamnionitis.

• Important clinical variants: Preterm premature rupture of membranes (preterm PROM) presents with fluid leakage but may lack contractions initially. Preeclampsia with preterm delivery presents with hypertension, proteinuria, and symptoms (headache, visual disturbances, right upper quadrant pain) rather than PTL symptoms. Subacute/chronic placental insufficiency may present with minimal contractions but with growth restriction or oligohydramnios on imaging.

• Clinical diagnosis criteria (mandatory): Regular uterine contractions (at least 4 contractions in 20 minutes, or 8 in 60 minutes) occurring between 20 and 37 weeks of gestation documented on tocometry, AND cervical change on serial examinations (cervical dilation ≥2 cm OR cervical effacement ≥80% OR cervical dilation 1-2 cm and cervical length <80% on ultrasound if initial exam cervix not fully effaced/dilated). A single examination showing cervical dilation ≥3 cm or effacement ≥80% at 20-37 weeks is also consistent with PTL. If contractions are present but cervix appears completely closed and uneffaced, the diagnosis is threatened preterm labor.

• Fetal fibronectin (fFN) testing: fFN is an extracellular matrix glycoprotein present at the maternal-fetal interface. Elevated fFN concentration (≥50 ng/mL) in cervicovaginal secretions between 16-34 weeks indicates breakdown of the fetal-maternal interface. Sensitivity is approximately 80-90% for predicting delivery within 7 days in symptomatic women with intact membranes; specificity is 70-80%. A negative result has excellent negative predictive value (~95-99%), allowing approximately 50% of women with threatened PTL symptoms to be safely discharged. Most clinical benefit occurs in the 24-34 week window. fFN positivity correlates with underlying inflammation/infection. The test is contaminated by intercourse, lubricants, and blood; sampling should occur 5 minutes after speculum placement and before digital cervical examination.

• Cervical length by transvaginal ultrasound: Transabdominal and translabial ultrasound are unreliable; transvaginal ultrasound is the gold standard. Cervical length <20 mm at 16-24 weeks identifies women at high risk for spontaneous PTB (positive likelihood ratio 5-10), while cervical length 20-30 mm represents intermediate risk. The cervix should be measured in the neutral position with the patient supine, and the measurement represents the distance from the internal cervical os to the external os. Serial measurements may show progressive shortening (cervical funneling), which increases PTB risk. Cervical length assessment is particularly valuable in asymptomatic high-risk women (prior PTB, singleton pregnancy) but also helps risk-stratify women presenting with PTL symptoms. When cervical dilation is apparent on speculum exam, transvaginal ultrasound may not add substantial information.

• Amniotic fluid studies: Amniocentesis is performed in selected cases (suspected intrauterine infection, unclear dating of pregnancy) to obtain amniotic fluid for: Gram stain and culture (identifies bacteria in 25-30% of PTL cases), glucose concentration (<15 mg/dL suggests bacterial infection), white blood cell count (elevated with infection), and IL-6 level (highly elevated in chorioamnionitis; cutoff values vary but levels >1000 pg/mL associated with high infection probability). Rapid PCR testing for bacteria is becoming available. Fetal lung maturity assessment (phosphatidylglycerol presence, lecithin:sphingomyelin ratio) may be performed on amniotic fluid in selected cases.

• Laboratory tests: Complete blood count (elevated WBC with left shift suggests infection or labor; anemia may indicate abruption), blood cultures (obtained if maternal fever present), urinalysis and urine culture (identifies asymptomatic bacteriuria or pyelonephritis), cervical/vaginal cultures for GBS (though prophylaxis is recommended regardless of culture result if PTB <35 weeks), and cultures for gonorrhea and chlamydia. In cases of fever or suspected chorioamnionitis, C-reactive protein and procalcitonin may be elevated but are nonspecific. Coagulation studies (PT, aPTT, fibrinogen, D-dimer) are obtained if abruption suspected.

• Obstetric ultrasound (general assessment): Confirm gestational age using obstetric parameters; establish fetal viability and number; assess amniotic fluid volume (polyhydramnios increases risk); evaluate fetal anatomy for major anomalies; assess fetal growth; and determine placental position (rule out previa or abruption). Umbilical artery and middle cerebral artery Doppler studies assess for placental insufficiency in growth-restricted fetuses.

• Tocometry/contraction monitoring: Continuous external tocometry documents uterine contraction frequency, duration, and intensity. True labor contractions occur at regular intervals, increase in intensity, and persist over

Immediate stabilisation and triage

• Confirm gestational age, fetal status, and rule out contraindications to prolonging pregnancy: continuous fetal monitoring and tocometry, assessment for chorioamnionitis, abruption, preeclampsia with severe features, or nonreassuring tracing. Tocolysis is contraindicated in each of these — delivery, not delay, is the treatment.
• Maternal transfer: ACOG recommends transfer to a facility with an appropriate-level NICU before delivery when anticipated birth is very preterm; in utero transfer beats neonatal transport.

First-line therapy (the interventions that change outcomes)

• Antenatal corticosteroids: betamethasone 12 mg IM ×2 doses 24 hours apart, or dexamethasone 6 mg IM every 12 hours ×4. ACOG recommends a single course from 24 0/7 to 33 6/7 weeks when delivery is anticipated within 7 days, with consideration from 22 weeks if resuscitation is planned, and a late-preterm course (34 0/7–36 6/7 weeks) in steroid-naive women. Mechanism: glucocorticoid-driven type II pneumocyte maturation and surfactant induction, plus accelerated gut and germinal matrix vascular maturation.
• Magnesium sulfate for fetal neuroprotection: ACOG/SMFM recommend IV magnesium when delivery before 32 weeks is expected, to reduce cerebral palsy — a neuroprotective, not tocolytic, indication.
• Group B Streptococcus prophylaxis: intrapartum IV penicillin G (ACOG) for preterm labor unless a recent negative screen. In non-anaphylactic penicillin allergy, cefazolin is appropriate; cross-reactivity is roughly 1–3% and side-chain driven. Severe (anaphylactic) allergy: clindamycin if the isolate is susceptible, otherwise vancomycin 20 mg/kg IV every 8 hours (maximum 2 g per dose) as specified by ACOG for this indication — fixed weight-based dosing, with no serum-level monitoring for such a short intrapartum course.

Tocolysis — buy 48 hours, nothing more

• Tocolysis is generally reserved for gestations below 34 weeks and is not indicated at or after 34 0/7 weeks, where the risks outweigh any neonatal gain.
• Calcium channel blocker (nifedipine) or NSAID (indomethacin) are first-line; indomethacin is restricted to before 32 weeks because prostaglandin inhibition constricts the ductus arteriosus and reduces fetal urine output.
• Beta-agonist (terbutaline) is second-line and carries an FDA warning against prolonged or oral use.
• Maintenance tocolysis, repeated courses of tocolysis, and bed rest are not recommended. This does not apply to steroids: a single rescue course of antenatal corticosteroids is a separate, ACOG-supported intervention when the prior course was given at least 14 days earlier, gestation is under 34 0/7 weeks, and delivery is anticipated within 7 days.

Cervical/definitive management

• Vaginal progesterone for an incidentally short cervix; cerclage for history-, ultrasound-, or exam-indicated cervical insufficiency in singletons. Cerclage in multiples is not beneficial and may be harmful. Remove cerclage at term or with established labor.
• PPROM before 34 weeks: latency antibiotics (ampicillin plus a macrolide, then oral amoxicillin plus erythromycin) per ACOG.

Neonatal complications (risk rises steeply with decreasing gestational age)

• Respiratory distress syndrome: surfactant deficiency raises alveolar surface tension and causes diffuse atelectasis — grunting, nasal flaring, retractions, and ground-glass opacification with air bronchograms on chest radiograph. Escalating oxygen requirement is the signal; treat with surfactant and CPAP.
• Intraventricular hemorrhage: the fragile germinal matrix vasculature bleeds with swings in cerebral perfusion — presents with apnea, seizures, bulging fontanelle, or an unexplained falling hematocrit. Screened for with head ultrasound in very preterm infants. Large IVH with hydrocephalus is an emergency.
• Necrotizing enterocolitis: immature gut barrier and mucosal ischemia with enteral feeding — abdominal distension, bloody stools, and pneumatosis intestinalis on abdominal radiograph. Portal venous gas or free air signals a surgical emergency.
• Bronchopulmonary dysplasia, retinopathy of prematurity, patent ductus arteriosus, early-onset sepsis, hypothermia, and hypoglycemia follow from organ immaturity; long-term cerebral palsy and neurodevelopmental impairment are the major late sequelae.

Maternal and obstetric complications

• Intraamniotic infection (chorioamnionitis): maternal fever with fundal tenderness, maternal and fetal tachycardia, purulent discharge. This is a delivery indication — tocolysis is contraindicated (ACOG). Untreated it progresses to sepsis and postpartum endometritis.
• Placental abruption: painful bleeding with a tender, hypertonic uterus and category III tracing — an obstetric emergency with risk of DIC.

Treatment-related complications

• Magnesium toxicity: progressive neuromuscular blockade — loss of deep tendon reflexes first, then respiratory depression, then cardiac arrest. Risk rises with renal impairment and oliguria. Emergency: stop infusion, give IV calcium gluconate.
• Before starting magnesium: myasthenia gravis is a contraindication, since magnesium impairs presynaptic acetylcholine release and can precipitate myasthenic crisis; in renal insufficiency the drug is renally cleared, so reduce dosing and monitor urine output, reflexes, and respiratory rate closely.
• Indomethacin: prostaglandin inhibition causes premature ductal constriction (tricuspid regurgitation/right heart strain on fetal echo) and oligohydramnios.
• Beta-agonists (terbutaline): maternal tachycardia, arrhythmia, hyperglycemia, hypokalemia, and pulmonary edema — especially with concurrent corticosteroids or fluid loading.
• Nifedipine: maternal hypotension; caution with concurrent magnesium.
• Corticosteroids: maternal hyperglycemia and transient reduction in fetal movement/heart rate variability — do not misread as fetal compromise.
• Cerclage: membrane rupture, infection, and cervical laceration if labor proceeds with the suture in place.

• The single best next step for preterm labor before 34 weeks is antenatal corticosteroids, not tocolysis. Tocolysis exists only to buy the ~48 hours needed for steroid benefit and maternal transfer. Give steroids even if delivery seems imminent — partial courses still help.
• Magnesium sulfate before 32 weeks is for fetal neuroprotection against cerebral palsy (ACOG/SMFM), not for tocolysis. This is the association examiners test most often, and the classic distractor is labeling magnesium a first-line tocolytic.
• A negative fetal fibronectin or a reassuring transvaginal cervical length carries a high negative predictive value — the stem is testing that you can safely discharge rather than admit and tocolyse.
• Maternal fever plus uterine tenderness plus fetal tachycardia equals intraamniotic infection: deliver and give antibiotics. Tocolysis and steroids-and-wait are wrong answers here.
• Indomethacin is restricted to before 32 weeks — premature closure of the ductus arteriosus and oligohydramnios are the buzzword adverse effects. Terbutaline must not be used for prolonged tocolysis (FDA warning); maternal pulmonary edema is the classic complication, amplified by concurrent corticosteroids.
• Loss of deep tendon reflexes is the earliest sign of magnesium toxicity; the answer is stop the infusion and give IV calcium gluconate before respiratory depression develops.
• Short cervix without a prior preterm birth → vaginal progesterone; short cervix with a prior spontaneous preterm birth → cerclage is offered. Cerclage in twins is not beneficial and may be harmful — a favorite distractor.
• Preterm labor mandates intrapartum GBS prophylaxis with IV penicillin G unless a recent negative screen exists. In non-anaphylactic penicillin allergy, cefazolin is acceptable; cross-reactivity is only about 1–3% and depends on shared R1 side chains.
• Bed rest, pelvic rest, hydration, and maintenance tocolysis do not prevent preterm birth — choosing them is the commonest error on management stems.